Vascular Smooth Muscle Cell Proliferation: Basic Investigations and New Therapeutic Approaches

• References

• 1 Dilley RJ, McGcachie JK, Prendergast FJ. A review of proliferative behavior, morphology and phenotypes of vascular smooth muscle. Atherosclerosis 1987; 63: 99-107
• 2 Libby P, Warner SJC, Solomon RN, Birinyi LK. Production of platelet-derived growth factor-like mitogen by smooth muscle cells from atheroma. N Engl.J Med 1988; 318: 1493-1498
• 3 Kuro-o M, Nagai R, Tsuchimoci H, Katoh H, Yazaki Y, Ohkubo A, Takaku F. Developmentally regulated expression of vascular smooth muscle myosin heavv chain isoforms. J Biol Chem 1989; 264: 18272-18275
• 4 Clowes AW, Clowes MM, Kocher O, Ropraz P, Chaponnier C, Gabbiani G. Arterial smooth muscle cells in vivo: Relationship between actin isoform expression and mitogenesis and their regulation by heparin. J Cell Biol 1988; 107: 1939-1945
• 5 Ross R, Raines EW, Bowen-Popc DF. The biology of platelet-derived growth factor. Cell 1986; 46: 155-169
• 6 Banscota NK, Taub R, Zellner K, King GL. Insulin, insulin-like growth factor I and platelet derived growth factor interact additively in the induction of the proto oncogene c-myc and cellular proliferation in cultured bovine aortic smooth muscle cells. Mol Endocrinol 1989; 3: 1183-1190
• 7 Libby P, Warner SJC, Friedman GB. Interleukin I: a mitogen for human vascular smooth muscle cells that induces the release of growth-inhibitory prostanoids. J Clin Invest 1988; 81: 487-498
• 8 Gay CG, Winkles JA. Interleukin I regulates heparin-binding growth factor 2 gene expression in vascular smooth muscle cells. Proc Natl Acad Sci USA 1991; 88: 296-300
• 9 Majack RA. Beta-type transforming growth factor specifies organizational behavior in vascular smooth muscle cell cultures. J Cell Biol 1987; 105: 465-471
• 10 Lindner V, Reidy MA. Proliferation of smooth muscle cells after vascular injury is inhibited by an antibody against basic fibroblast growth factor. Proc Natl Acad Sci USA 1991; 88: 3739-3743
• 11 Kindy MS, Sonenshcin GE. Regulation of oncogene expression in cultured aortic smooth muscle celts. J Biol Chem 1986; 261: 12865-12868
• 12 Kawamoto S, Adelstein RS. Characterization of myosin heavy chains in cultured aorta smooth muscle cells. J Biol Chem 1987; 262: 7282-7288
• 13 Toulme JJ, Helene C. Anlimessenger oligodeoxyribonucleotidcs: an alternative to antisense RNA for artificial regulation of gene expression—a review. Gene 1988; 72: 51-58
• 14 Thompson CB, Challoner PB, Neiman PE, Groudine M. Expression of the c-myb proto-oncogene during cellular proliferation. Nature 1986; 319: 374-380
• 15 Reilly CF, Kindy MS, Brown KE, Rosenberg RD, Sonenshein GE. Heparin prevents vascular smooth muscle cell progression through the Gl phase of the cell cycle. J Biol Chem 1989; 264: 6990-6995
• 16 Travali S, Ferber A, Reiss K, Sell C, Koniecki J, Calabretta B, Baserga R. Effect of the myb gene product on the expression of the PCN A gene in fibroblasts. Oncogene 1991; 6: 887-894
• 17 Clowes AW, Karnovsky MJ. Suppression by heparin of smooth muscle cell proliferation in injured arteries. Nature 1977; 265: 625-626
• 18 Reilly CF, Fritze LMS, Rosenberg RD. Antiproliferative effects of heparin on vascular smooth muscle cells are reversed by epidermal growth factor. J Cell Physiol 1986; 131: 149-157
• 19 Guyton JR, Rosenberg RD, Clowes AW, Karnovsky MJ. Inhibition of rat arterial smooth muscle proliferation by heparin. Circ Res 1980; 46: 625-634
• 20 Fritze LMS, Reilly CF, Rosenberg RD. An antiproliferative heparan sulfate species produced by postconfluent smooth muscle cells. J Cell Biol 1985; 100: 1041-1049
• 21 Simons M, Rosenberg RD. Antisense nonmuscle myosin heavy chain and c-myb oligonucleotides suppress smooth muscle cell proliferation in vitro. Circ Res 1992; 70: 835-843
• 22 Simons M, Morgan KG, Parker C, Collins E, Rosenberg RD. The proto-oncogene c-myb mediates an intracellular calcium rise during the late Gl phase of the cell cycle. J Biol Chem 1993; 268: 627-632
• 23 Keith CH, Ratan R, Maxfield FR, Bajer A, Shelanski Z. Local cytoplasmic calcium gradients in living mitotic cells. Nature 1985; 316: 848-850
• 24 Poenie M, Alderton J, Steinhardt R, Tsien R. Calcium rises abruptly and briefly throughout the cell at the onset of anaphase. Science 1986; 233: 886-889
• 25 Steinhardt RA, Alderton J. Intracellular free calcium rise triggers nuclear envelope breakdown in the sea urchin embryo. Nature 1988; 332: 364-366
• 26 Twigg J, Patel R, Whitaker M. Translational control of InsP3-induced chromatin condensation during the early cell cycles of sea urchin embryos. Nature 1988; 332: 366-369
• 27 Sisken JE, Silver RB, Barrows GH, Grasch SD. Studies on the role of Ca++ in cell division with the use of fluorescent probes and quantitative video intensification microscopy. In: Advances in Microscopy. Cowden RR, Harrison FW. (eds) Alan R Liss; New York: 1985. pp. 73-87
• 28 Mcintosh JR, Koonce MP. Mitosis. Science 1989; 246: 622-628
• 29 Paul D, Ristom HJJ. Cell cycle control bv Ca++ ions in mouse 3T3 cells and in transformed 3T3 cells. J Cell Physiol 1979; 98: 31-40
• 30 Pardee AB, Dubrow R, Hamlin JL, Kletzien RF. Animal cell cycle. Ann Rev Biochem 1978; 47: 715-750
• 31 Luscher B, Eisenman RN. New light on Myc and Myb. Part II. Myb. Genes Dev 1990; 4: 2235-2241
• 32 Evans JL, Moore TL, Kuehl WM, Bender T, Ting JP. Functional analysis of c-Myb protein in T-lymphocytic cell lines shows that it transactivates the c-Myc promoter. Mol Cell Biol 1990; 10: 5747-5752
• 33 Dudek H, Tantravahiv RV, Rao VN, Reddy ES, Reddy EP. Myb and Ets proteins cooperate in transcriptional activation of the mim-1 promoter. Proc Natl Acad Sci USA 1992; 89: 1291-1295
• 34 Iida H, Sakaguchi S, Yagawa Y, Anraku Y. Cell cycle control by Ca²⁺ in Saccharomyees cerevisiae . J Biol Chem 1990; 265: 21216-21222
• 35 Chafouleas JG, Bolton WE, Hidaka H, Boyd III AE, Means AR. Calmodulin and the cell cycle: Involvement in regulation of celt-cycle progression. Cell 1982; 28: 41-50
• 36 Rasmussen CD, Means AR. Calmodulin is required for cell-cycle progression during G1 and mitosis. EMBO J 1989; 8: 73-82
• 37 Simons M, Edelman ER, DeKeyser JL, Langer RS, Rosenberg RD. Antisense c-myb oligonucleotides suppress smooth muscle accumulation in vivo. Nature 1992; 359: 67-70
• 38 Deuel TF, Huang JS. Platelet-derived growth factor. Structure, function, and roles in normal and transformed cells. J Clin Invest 1984; 74: 669-676
• 39 Lindner V, Lappi DA, Baird A, Majack RA, Reidy MA. Role of basic fibroblast growth factor in vascular lesion formation. Circ Res 1991; 68: 106-113
• 40 Jawien A, Bowcn-Pope DF, Lindner V, Schwartz SM, Clowes AM. Platelet-derived growth factor promotes smooth muscle migration and intimal thickening in a rat model of balloon angioplasty. J Clin Invest 1992; 89: 507-511
• 41 Hansson GK, Jonasson L, Holm J, Clowes MM, Clowes AW. Alpha-interferon regulates vascular smooth muscle proliferation and la antigen expression in vivo and in vitro. Circ Res 1988; 63:: 712-719
• 42 Ferns GA, Raines EW, Sprugel KH, Motani AS, Reidy MA, Ross R. Inhibition of neoinlimal smooth muscle accumulation after angioplasty by an antibody to PDGF. Science 1991; 253: 1129-1132
• 43 Nobuyoshi M, Kimura T, Ohishi H, Horiuchi H, Nosaka H, Hamasa-ki N, Yokoi H, Kim KJ. Restenosis after percutaneous transluminal coronary angioplasty: Pathology observations in twenty patients. Am Coll Cardiol 1991; 17: 433-439
• 44 Jonasson L, Holm J, Hannson GK. Cyclosporin A inhibits smooth muscle proliferation in the vascular response to injury. Proc Natl Acad Sci USA 1988; 85: 2303-2306
• 45 Powell JS, Clozel JP, Muller RK, Kuhn H, Hefti F, Hosang M, Baumgartner HR. Inhibitors of angiotensin-converting enzyme prevent myointimal proliferation after vascular injury. Science 1989; 245: 186-188
• 46 Pukac LA, Hirsch GM, Lormeau JC, Petitou M, Choay J, Karnovsky M. Antiproliferative effects of novel, nonanticoagulant heparin derivatives on vascular smooth muscle cell in vitro and in vivo. Am J Pathol 1991; 139: 1501-1509